Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis

Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis have?

Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis has 23 citations in the OpenAlex counts ScholarIQ stores.

When was Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis published?

Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis has 2023 year in the ScholarIQ index.

What is the open-access status of Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis?

Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis has gold oa status in the ScholarIQ index.

What is the DOI of Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis?

The DOI for Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis is on the source record.

What is the PMID of Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis?

The PMID for Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis is on the source record.

What is the OpenAlex record for Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis?

The OpenAlex for Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis is on the source record.